Financials
Financial year 2025
PharmaPhoto from Genk, company number BE0771989544, closed financial year 2025 with a result of € 9,556 after tax. For that financial year PharmaPhoto recorded a gross margin of € 9,856 and equity of € 7,609. Compared with financial year 2024, the result moved from € -23,639 to € 9,556. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 10, 2026.
€ 7,609
▲ € 9,556 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 9,556
▲ still € 23,639 loss in 2024
Profit after tax over the fiscal year.
€ 7,877
▲ 20% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -2,391.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 28,019
▼ 39% vs 2024
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 29,679 | € 13,161 | € -19,859 | € 9,856 | ▲ € 29,716 |
| Profit after taxes | € 928 | € 10,452 | € -23,639 | € 9,556 | ▲ € 33,196 |
| Equity | € 11,239 | € 21,691 | € -1,948 | € 7,609 | ▲ € 9,556 |
| Total debts | € 80,967 | € 73,985 | € 78,709 | € 59,091 | ▼ 25% |
| Cash | € 35,545 | € 10,203 | € 6,577 | € 7,877 | ▲ 20% |
| Retained profit | € 1,239 | € 11,691 | € -11,948 | € -2,391 | ▲ € 9,556 |
| Bank debt | € 1,134 | € 0 | € 0 | € 0 | |
| Balance sheet total | € 92,206 | € 95,677 | € 76,761 | € 66,699 | ▼ 13% |
Key figures of PharmaPhoto, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PharmaPhoto?
What happened at PharmaPhoto in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 9,556. Source: NBB ↗
- New establishment in Genk. KBO
- Start of the company according to the CBE. KBO
In short
From € 928 profit in 2022 to € 9,556 profit in 2025.
Paid € 2,845 in corporate taxes since 2022.
Best year ever: 2023, with € 10,452 profit.
A new publication or filing at PharmaPhoto? We notify you, reason included.
Follow PharmaPhotoDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind PharmaPhoto are Bart Bollen, Marc Vandervelden, De Zorgbasis BV, Kris Bollen BV and X-Design Pro BV. The same people are also behind Digital Pharma. Bart Bollen is also behind INTEGRATED MATERIAL CONTROL ENGINEERING, Bindus and ALL-INN SERVICES. Marc Vandervelden is also behind APOTHEEK BOLLEN ELS and GROENMOLEN. De Zorgbasis BV is also behind APOTHEEK MARKT MAASEIK.
Directors
According to the 2025 annual accounts
Bart Bollen
Director
Also active at: INTEGRATED MATERIAL CONTROL ENGINEERING, Bindus, Digital Pharma, ALL-INN SERVICES
Director · represented by Els Bollen
Also active at: APOTHEEK MARKT MAASEIK, Digital Pharma
Director · represented by Geert Bollen
Also active at: Bindus, Digital Pharma, ALL-INN SERVICES
Establishments
Establishment units
Physical locations of this company
Slingerweg 52
3600 Genk
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 7 companies are registered at this address.
All companies at this address →INTEGRATED MATERIAL CONTROL ENGINEERING same network
€ 297,971 gross margin · 2025
Bindus same network
€ 171,132 gross margin · 2025
BIPCO
Bimaco
Digital Pharma same network
€ 305,130 gross margin · 2025
+2 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0771.989.544
- VAT number
- BE 0771.989.544
- Registered office
- Slingerweg 52, 3600 Genk
- Names & denominations
- PharmaPhoto
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 4 August 2021
- Peppol
- Active · Active since 9 Oct 2025
- Activities · NACE
Computerinfrastructuur, gegevensverwerking, hosting en aanverwante activiteiten
Gegevensverwerking, webhosting en aanverwante activiteiten
Ontwerpen van computerprogramma’s
Uitgeven van overige software
Grafisch ontwerp en visuele communicatie
Activiteiten van grafische designers
Ontwerpen en programmeren van computerprogramma's